Pancreatic Cancer Research

ResearcherTongji HospitalActive in the last 2 years

Yuchong Zhao

Matched on ORCID iD 0000-0003-2245-8541; OpenAlex author ID A5062180989. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 5)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 4 papers · 2026: 2 papers

Papers 10

  1. Cancer-Associated Fibroblast-Derived Sphingosine-1-Phosphate Activates a MALL-SDC4 Axis to Facilitate Perineural Invasion in Pancreatic Cancer. Last author DOI 10.1002/advs.75426↗
  2. CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK. Last author DOI 10.1038/s41389-026-00634-0↗
  3. PPY-Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer. Last author DOI 10.1002/advs.202413432↗
  4. Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer. Last author DOI 10.1016/j.isci.2024.111612↗
  5. Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer. Last author DOI 10.1093/carcin/bgae072↗
  6. Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer. First author DOI 10.1136/jitc-2025-012144↗
  7. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells. Co-author DOI 10.1038/s41419-024-06482-3↗
  8. Diagnostic and Prognostic Values of KRAS Mutations on EUS-FNA Specimens and Circulating Tumor DNA in Patients With Pancreatic Cancer. First author DOI 10.14309/ctg.0000000000000487↗
  9. Targeted intervention of eIF4A1 inhibits EMT and metastasis of pancreatic cancer cells via c-MYC/miR-9 signaling. Co-author DOI 10.1186/s12935-021-02390-0↗
  10. Endoscopic ultrasound-guided radiofrequency ablation of unresectable pancreatic cancer with low ablation power and multiple applications: a preliminary study o… Co-author DOI 10.21037/apm-20-1468↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bin Cheng · 10 shared papers, 2021–2026 · strength 1.99
  2. Mengdie Cao · 7 shared papers, 2024–2026 · strength 1.57
  3. Jingwen Liang · 7 shared papers, 2024–2026 · strength 1.57
  4. Luyao Liu · 6 shared papers, 2024–2026 · strength 1.35
  5. Shiru Chen · 5 shared papers, 2025–2026 · strength 1.15
  6. Wang Peng · 4 shared papers, 2025–2026 · strength 0.93
  7. Zhou Luan · 4 shared papers, 2021–2026 · strength 0.79
  8. Ronghua Wang · 3 shared papers, 2022–2025 · strength 0.59
  9. Jinlin Wang · 3 shared papers, 2021–2025 · strength 0.51
  10. Yilei Yang · 1 shared paper, 2025 · strength 0.22
  11. Wei Chen · 1 shared paper, 2025 · strength 0.22
  12. Wei Chen · 1 shared paper, 2024 · strength 0.19
  13. Yun Wang · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.